Pemetrexed for previously treated patients with metastatic gastric cancer: a prospective phase II study

BACKGROUND: Gastric cancer is one of the leading causes of cancer-related death worldwide. There were debates on the value of the second-line and beyond chemotherapy by the time we designed this trial. So we designed this phase II trial to assess the efficacy and safety of pemetrexed in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, D S, Jin, Y, Luo, H Y, Wang, Z Q, Qiu, M Z, Wang, F H, Li, Y H, Xu, R H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453460/
https://www.ncbi.nlm.nih.gov/pubmed/25474247
http://dx.doi.org/10.1038/bjc.2014.607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453460/
https://www.ncbi.nlm.nih.gov/pubmed/25474247
http://dx.doi.org/10.1038/bjc.2014.607

Ejemplares similares